Patents by Inventor Michael Robin

Michael Robin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9492425
    Abstract: The disclosure relates to new crystalline forms of genistein. The disclosed crystalline forms include crystalline genistein sodium salt dihydrate; crystalline genistein potassium salt dihydrate; crystalline genistein calcium salt; crystalline genistein magnesium salt; crystalline genistein L-lysine salt; crystalline genistein N-methylglucamine salt; crystalline genistein N-ethylglucamine salt; crystalline genistein diethylamine salt; and crystalline genistein monohydrate. The disclosure also relates to the novel genistein salts represented by these crystalline forms. Therapeutic compositions containing at least one of these crystalline forms of genistein and/or a genistein salt and a pharmaceutically acceptable carrier are described.
    Type: Grant
    Filed: April 20, 2015
    Date of Patent: November 15, 2016
    Assignee: AXCENTUA PHARMACEUTICALS AB
    Inventors: Anders Berkenstam, Stefan Rehnmark, Michael-Robin Witt, Keith Lorimer, Stephen Watt
  • Patent number: 9402902
    Abstract: The present invention provides a method of treatment or prophylaxis of enteric disease caused by Gram negative bacteria. The method includes the step of administering a vaccine or a hyperimmune material raised against said vaccine to an individual. The vaccine comprises one or more cell wall antigens reactive in a manner characteristic of O group serotypes, or reactive in a manner characteristic of lipopolysaccharide associated antigens, and at least some of said antigens are separated from bacterial cell walls or wall fragments. The invention also provides composition containing hyperimmune material as well as uses of the composition and vaccine.
    Type: Grant
    Filed: December 23, 2013
    Date of Patent: August 2, 2016
    Assignee: Immuron Limited
    Inventors: Roy Michael Robins-Browne, Grant Thomas Rawlin, Gottfried Lichti
  • Publication number: 20160154772
    Abstract: In many environments such as municipal, military and construction the use of digital and paper systems permits end users to create or modify features on digital document, attributes associated with those features, or attribute values associated with those features. The attribute value management system includes a digital pen, at least one digital document, one or more computing devices, and a number of software programs for creating data relationships between the digital documents (e.g., features on maps and their underlying attribute values), interpreting voice or handwritten data, validating the interpreted data, and uploading the validated data to a geo-database. The attribute value management system functions to create, update or otherwise change the attribute values associated with the features by a temporal association method; a linked identification method; or a direct handwriting method.
    Type: Application
    Filed: June 9, 2014
    Publication date: June 2, 2016
    Inventors: Michael Robin, Phil Cohen
  • Publication number: 20150290166
    Abstract: The disclosure relates to new crystalline forms of genistein. The disclosed crystalline forms include crystalline genistein sodium salt dihydrate; crystalline genistein potassium salt dihydrate; crystalline genistein calcium salt; crystalline genistein magnesium salt; crystalline genistein L-lysine salt; crystalline genistein N-methylglucamine salt; crystalline genistein N-ethylglucamine salt; crystalline genistein diethylamine salt; and crystalline genistein monohydrate. The disclosure also relates to the novel genistein salts represented by these crystalline forms. Therapeutic compositions containing at least one of these crystalline forms of genistein and/or a genistein salt and a pharmaceutically acceptable carrier are described.
    Type: Application
    Filed: April 20, 2015
    Publication date: October 15, 2015
    Applicant: AXCENTUA PHARMACEUTICALS AB
    Inventors: Anders BERKENSTAM, Stefan REHNMARK, Michael-Robin WITT, Keith LORIMER, Stephen WATT
  • Patent number: 9012495
    Abstract: The disclosure relates to new crystalline forms of genistein. The disclosed crystalline forms include crystalline genistein sodium salt dihydrate; crystalline genistein potassium salt dihydrate; crystalline genistein calcium salt; crystalline genistein magnesium salt; crystalline genistein L-lysine salt; crystalline genistein N-methylglucamine salt; crystalline genistein N-ethylglucamine salt; crystalline genistein diethylamine salt; and crystalline genistein monohydrate. The disclosure also relates to the novel genistein salts represented by these crystalline forms. Therapeutic compositions containing at least one of these crystalline forms of genistein and/or a genistein salt and a pharmaceutically acceptable carrier are described.
    Type: Grant
    Filed: December 11, 2009
    Date of Patent: April 21, 2015
    Assignee: Axcentua Pharmaceuticals AB
    Inventors: Anders Berkenstam, Stefan Rehnmark, Michael-Robin Witt, Keith Lorimer, Stephen Watt
  • Publication number: 20140298150
    Abstract: In many environments such as municipal, military and construction the use of digital and paper systems permits end users to create or modify features on digital document, attributes associated with those features, or attribute values associated with those features. The attribute value management system includes a digital pen, at least one digital document, one or more computing devices, and a number of software programs for creating data relationships between the digital documents (e.g., features on maps and their underlying attribute values), interpreting voice or handwritten data, validating the interpreted data, and uploading the validated data to a geo-database. The attribute value management system functions to create, update or otherwise change the attribute values associated with the features by a temporal association method; a linked identification method; or a direct handwriting method.
    Type: Application
    Filed: June 9, 2014
    Publication date: October 2, 2014
    Inventors: Michael Robin, Phil Cohen
  • Publication number: 20140161953
    Abstract: The grill of the present disclosure provides multiple heating zones within a front-to-back direction of each cooking platen. Each cooking zone has a heating element associated therewith. The heating elements can be independently controlled, so that each of the heating zones can be operated at a different temperature if necessary. A controller can monitor and adjust the heat output of each element with a temperature probe that measures the temperature of the surface of the grill plate. One or more of the heating elements can be a gas burner. Electrical heating elements may also be used.
    Type: Application
    Filed: December 11, 2013
    Publication date: June 12, 2014
    Applicant: GARLAND COMMERCIAL INDUSTRIES, LLC
    Inventors: Douglas S. JONES, Michael Robin SYKES, Christopher John REIS
  • Publication number: 20140161952
    Abstract: The grill of the present disclosure provides a multi-zone cooking surface with separate, discrete zones that are thermally isolated from one another. This allows for cooking in only one zone while avoiding the problem of heat loss to adjacent zones that are not in use, or are operating at different or lower temperatures. The individual cooking zones are separated by a gap that is filled with a thermally insulating material. Each zone can have an independent associated temperature control.
    Type: Application
    Filed: December 10, 2013
    Publication date: June 12, 2014
    Applicant: GARLAND COMMERCIAL INDUSTRIES, LLC
    Inventor: Michael Robin SYKES
  • Patent number: 8719718
    Abstract: A digital paper-enabled product includes digital paper with a digital pattern that spatially cooperates with one or more features or boundaries printed on the pattern. More specifically, a system cooperating with the product may include spatial information systems that manage the features or boundaries and communicates with a writing instrument that was used to effect changes to the digital paper-enabled product. In one embodiment, the digital paper-enabled product may take the form of a sheet of digital paper bearing a digital pattern and where action icons (e.g. user intended actions) and/or features (e.g. such as map features) or a spatial reference frame are printed onto the digital pattern and where at least one action palette is printed onto the digital pattern, correlated therewith, and usable to effect changes to the product.
    Type: Grant
    Filed: May 9, 2008
    Date of Patent: May 6, 2014
    Inventors: Erik M. Erikson, R. Matthews Wesson, Ira Smith, David McGee, Phil Cohen, Philipp Schmid, Michael Robin, Alex A. Arthur, Paulo Barthelmess
  • Publication number: 20140112938
    Abstract: The present invention provides a method of treatment or prophylaxis of enteric disease caused by Gram negative bacteria. The method includes the step of administering a vaccine or a hyperimmune material raised against said vaccine to an individual. The vaccine comprises one or more cell wall antigens reactive in a manner characteristic of O group serotypes, or reactive in a manner characteristic of lipopolysaccharide associated antigens, and at least some of said antigens are separated from bacterial cell walls or wall fragments. The invention also provides composition containing hyperimmune material as well as uses of the composition and vaccine.
    Type: Application
    Filed: December 23, 2013
    Publication date: April 24, 2014
    Applicant: Immuron Limited
    Inventors: Roy Michael Robins-Browne, Grant Thomas Rawlin, Gottfried Lichti
  • Patent number: 8637025
    Abstract: The present invention provides a method of treatment or prophylaxis of enteric disease caused by Gram negative bacteria. The method includes the step of administering a vaccine or a hyperimmune material raised against said vaccine to an individual. The vaccine comprises one or more cell wall antigens reactive in a manner characteristic of O group serotypes, or reactive in a manner characteristic of lipopolysaccharide associated antigens, and at least some of said antigens are separated from bacterial cell walls or wall fragments. The invention also provides composition containing hyperimmune material as well as uses of the composition and vaccine.
    Type: Grant
    Filed: March 4, 2004
    Date of Patent: January 28, 2014
    Assignee: Immuron Limited
    Inventors: Roy Michael Robins-Browne, Grant Thomas Rawlin, Gottfried Lichti
  • Patent number: 8610356
    Abstract: An iodine fueled plasma generator system includes a plasma generator. At least one storage vessel is configured to store condensed phase iodine therein. A heating device proximate to the storage vessel is configured to create iodine vapor from the condensed phase iodine. A propellant management subsystem is configured to deliver the iodine vapor to the plasma generator. A feedback control subsystem is responsive to one or more of plasma generator discharge current, the pressure of the iodine vapor, and/or the temperature of the iodine vapor configured to regulate the flow rate of the iodine vapor to the plasma generator.
    Type: Grant
    Filed: July 27, 2012
    Date of Patent: December 17, 2013
    Assignee: Busek Co., Inc.
    Inventors: James J. Szabo, Jr., Bruce Pote, Surjeet Paintal, Michael Robin, Vladimir Hruby
  • Patent number: 8564548
    Abstract: A digital palette and a digital pen device are used to create or manipulate a digital document to provide complex information using features, such as graphical features selected from stencils, shapes, and connectors and possibly to apply one or more attributes to the digital document. The digital palette may have a custom layout. The features on the digital palette may be selected from a variety of sources, such as digital stencil libraries. The digital palette and digital document may be arranged on the same or different sheets of digital paper overlying one or more digital patterns. Information communicated from the digital palette to the digital document may be uploaded, processed, reviewed, changed and stored in a computer. Lastly, the digital document may be finalized and printed to incorporate all changes previously made using the digital palette, the digital pen device and the computer.
    Type: Grant
    Filed: May 26, 2009
    Date of Patent: October 22, 2013
    Assignee: Adapx, Inc.
    Inventors: Michael Robin, Paulo Barthelmess, David McGee, Philipp Schmid, Phil Cohen
  • Publication number: 20130026920
    Abstract: An iodine fueled plasma generator system includes a plasma generator. At least one storage vessel is configured to store condensed phase iodine therein. A heating device proximate to the storage vessel is configured to create iodine vapor from the condensed phase iodine. A propellant management subsystem is configured to deliver the iodine vapor to the plasma generator. A feedback control subsystem is responsive to one or more of plasma generator discharge current, the pressure of the iodine vapor, and/or the temperature of the iodine vapor configured to regulate the flow rate of the iodine vapor to the plasma generator.
    Type: Application
    Filed: July 27, 2012
    Publication date: January 31, 2013
    Applicant: BUSEK COMPANY, INC.
    Inventors: James J. Szabo, JR., Bruce Pote, Surjeet Paintal, Michael Robin, Vladimir Hruby
  • Publication number: 20130022619
    Abstract: The present invention provides methods and compositions useful in the field of medicine, and particularly in the treatment of viral infections. More particularly, the invention relates to the use of methods and compositions for the inhibition of human immunodeficiency virus (HIV) transmission.
    Type: Application
    Filed: April 11, 2011
    Publication date: January 24, 2013
    Inventors: Grant Thomas Rawlin, Damian Francis John Purcell, Robert John Center, Marit Kramski, Roy Michael Robins-Browne, Gottfried Lichti
  • Publication number: 20130015142
    Abstract: A method of and system for treating water to reduce the level of trihalomethanes or other volatile contaminants such as radon includes the water to be treated (WTBT) being sprayed through a nozzle to aerate the WTBT to increase the air/water interface therein reducing the level of trihalomethanes in the water. In one embodiment, the pressure of the WTBT in the nozzle is adjusted and the nozzle is selected to have a nozzle orifice such that the droplet size of the water to be treated from the nozzle is less than 2000 microns SMD. In addition, the nozzle is spaced from a holding tank for receiving and collecting the sprayed water such that the surface of the treated water is specified at a particular distance based on desired treatment goals.
    Type: Application
    Filed: June 11, 2012
    Publication date: January 17, 2013
    Inventors: Ethan Brooke, Michael Robin Collins
  • Publication number: 20130015133
    Abstract: The system and method reduces volatile organic compound concentration in a water distribution system using pressurized diffused aeration. The system and method is used in-line in a water distribution system. The system and method can be used at the ends of the distribution system where volatile organic compounds, including trihalomethanes, are more likely to persist. The system and method of pressurized, diffused aeration reduces volatile organic compounds from groundwater remediation systems as well.
    Type: Application
    Filed: February 16, 2012
    Publication date: January 17, 2013
    Inventors: Ethan Brooke, Michael Robin Collins, John Michael Zwerneman
  • Publication number: 20120066578
    Abstract: In many environments such as municipal, military and construction the use of digital pen and paper systems permits end users to create or modify features on digital document, attributes associated with those features, or attribute values associated with those features. The attribute value management system includes a digital pen, at least one digital document, one or more computing devices, and a number of software programs for creating data relationships between the digital documents (e.g., features on maps and their underlying attribute values), interpreting voice or handwritten data, validating the interpreted data, and uploading the validated data to a geo-database. The attribute value management system functions to create, update or otherwise change the attribute values associated with the features by a temporal association method; a linked identification method; or a direct handwriting method.
    Type: Application
    Filed: August 9, 2011
    Publication date: March 15, 2012
    Applicant: ADAPX, INC.
    Inventors: Michael Robin, Philip R. Cohen, Melissa Trapp Petty
  • Publication number: 20120054601
    Abstract: Methods, techniques, and systems for icon automated generation and placement are provided. Some embodiments provide an icon generation and placement system configured to ingest one or more icon templates, wherein the icon templates comprise an icon symbol, an icon label, and an icon dimensionality; populate source data for the one or more icon templates, wherein the source data is accessible by at least one of a speech recognition subsystem, handwriting recognition subsystem, and sketch recognition subsystem; generate an icon attribute table for the one or more icon templates; store the ingested one or more icon templates in an icon database; and place an icon, from the icon database into a selected location within a digital document in response to one or more multimodal inputs.
    Type: Application
    Filed: May 31, 2011
    Publication date: March 1, 2012
    Applicant: ADAPX, INC.
    Inventors: Philip R. Cohen, R. Matthews Wesson, Michael Robin, David R. McGee
  • Publication number: 20120035253
    Abstract: The disclosure relates to new crystalline forms of genistein. The disclosed crystalline forms include crystalline genistein sodium salt dihydrate; crystalline genistein potassium salt dihydrate; crystalline genistein calcium salt; crystalline genistein magnesium salt; crystalline genistein L-lysine salt; crystalline genistein N-methylglucamine salt; crystalline genistein N-ethylglucamine salt; crystalline genistein diethylamine salt; and crystalline genistein monohydrate. The disclosure also relates to the novel genistein salts represented by these crystalline forms. Therapeutic compositions containing at least one of these crystalline forms of genistein and/or a genistein salt and a pharmaceutically acceptable carrier are described.
    Type: Application
    Filed: December 11, 2009
    Publication date: February 9, 2012
    Inventors: Anders Berkenstam, Stefan Rehnmark, Michael-Robin Witt, Keith Lorimer, Stephen Watt